512 related articles for article (PubMed ID: 19614767)
1. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
[TBL] [Abstract][Full Text] [Related]
2. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
Agaimy A; Terracciano LM; Dirnhofer S; Tornillo L; Foerster A; Hartmann A; Bihl MP
J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230
[TBL] [Abstract][Full Text] [Related]
3. The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs.
Sápi Z; Füle T; Hajdu M; Matolcsy A; Moskovszky L; Márk A; Sebestyén A; Bodoky G
Diagn Mol Pathol; 2011 Mar; 20(1):22-33. PubMed ID: 21326036
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST).
Daniels M; Lurkin I; Pauli R; Erbstösser E; Hildebrandt U; Hellwig K; Zschille U; Lüders P; Krüger G; Knolle J; Stengel B; Prall F; Hertel K; Lobeck H; Popp B; Theissig F; Wünsch P; Zwarthoff E; Agaimy A; Schneider-Stock R
Cancer Lett; 2011 Dec; 312(1):43-54. PubMed ID: 21906875
[TBL] [Abstract][Full Text] [Related]
5. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series.
Gomes AL; Gouveia A; Capelinha AF; de la Cruz D; Silva P; Reis RM; Pimenta A; Lopes JM
J Clin Pathol; 2008 Feb; 61(2):203-8. PubMed ID: 17827398
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
[TBL] [Abstract][Full Text] [Related]
7. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
[TBL] [Abstract][Full Text] [Related]
8. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
9. "Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior.
Rege TA; Wagner AJ; Corless CL; Heinrich MC; Hornick JL
Am J Surg Pathol; 2011 Apr; 35(4):495-504. PubMed ID: 21358303
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumours.
Sihto H; Franssila K; Tanner M; Vasama-Nolvi C; Sarlomo-Rikala M; Nupponen NN; Joensuu H; Isola J
Scand J Gastroenterol; 2006 Jul; 41(7):805-11. PubMed ID: 16785193
[TBL] [Abstract][Full Text] [Related]
11. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.
Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G
J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors.
Daum O; Grossmann P; Vanecek T; Sima R; Mukensnabl P; Michal M
Ann Diagn Pathol; 2007 Feb; 11(1):27-33. PubMed ID: 17240304
[TBL] [Abstract][Full Text] [Related]
13. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size.
Rossi S; Gasparotto D; Toffolatti L; Pastrello C; Gallina G; Marzotto A; Sartor C; Barbareschi M; Cantaloni C; Messerini L; Bearzi I; Arrigoni G; Mazzoleni G; Fletcher JA; Casali PG; Talamini R; Maestro R; Dei Tos AP
Am J Surg Pathol; 2010 Oct; 34(10):1480-91. PubMed ID: 20861712
[TBL] [Abstract][Full Text] [Related]
14. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
Lasota J; Miettinen M
Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM
Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765
[TBL] [Abstract][Full Text] [Related]
17. PDGFRA immunostaining can help in the diagnosis of gastrointestinal stromal tumors.
Miselli F; Millefanti C; Conca E; Negri T; Piacenza C; Pierotti MA; Tamborini E; Pilotti S
Am J Surg Pathol; 2008 May; 32(5):738-43. PubMed ID: 18360281
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic and ligand-dependent activation of KIT/PDGFRA in surgical samples of imatinib-treated gastrointestinal stromal tumours (GISTs).
Negri T; Bozzi F; Conca E; Brich S; Gronchi A; Bertulli R; Fumagalli E; Pierotti MA; Tamborini E; Pilotti S
J Pathol; 2009 Jan; 217(1):103-12. PubMed ID: 18973210
[TBL] [Abstract][Full Text] [Related]
20. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
